Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q1 FY27 Earnings Presentation
22 slides from Amrutanjan Health Care's earnings presentation, Aug 11, 2026
Slide 1: poy] eveg yyjeoH uefue;nsmy
poy] eveg yyjeoH uefue;nsmy 4991IYO aoue!|dwWiod 9 Aieja199g AueduioD je6e7 - szaBeuepw jessuay (HONIS L33ud NVOVS) 10€,S0+ 02:ZE:0Z 7ZL'80°97Z0Z :83eq H ONIS 445ud HONIS 134ud NYOVD Aq paubls Aje3161q NV9OVD pay eseg yyeeH uefueynimy Jo4 “puodal UO aAoge ay} aye} 0} NOA Jsanbay “9Z0Z EUNP AOE Papua
Slide 2: Investor Presentation Quarter Ended 30th June 2026
Amrutanjan Health Care Limited Investor Presentation Quarter Ended 30* June 2026 Date: 11°" August 2026
Slide 3: Contents
Contents a. Business Update 1. Segment Performance 2. Operations b. Financials 1. Q1FY27 Performance c. Management Commentary Investor Presentation | Quarter Ended 30th June 2026
Slide 4: Business Update
Business Update YG Investor Presentation | Quarter Ended 30th June 2026
Slide 5: AHCL Power Brands
AHCL Power Brands (Gross Sales Nos.) Pain Management: 57.0 Crs Congestion: 2.3 Crs | Women’s 7 Hygiene: Rehydration: 36.9 Crs LE : 65 ‘ =) sen 9.3 Crs Investor Presentation | Quarter Ended 30th June 2026
Slide 6: Q1 FY 26-27: Women's Hygiene witnessed double digit growth
Q1 FY 26-27: Women’s Hygiene witnessed double digit growth along with growth in Congestion and Rehydration (Gross Sales Growth) (| Pain Management (P >) Congestion (i Women’s Hygiene 1: (- Rehydration >») Brand Amrutanjan Growth Q1 FY 26-27 Ne Body ache Investor Presentation | Quarter Ended 30th Jun
Slide 7: Segment Performance: Pain Management and Congestion
Segment Performance: Pain Management and Congestion Head ache | Head ache (Brand Amrutanjan) | Amrutanjan) Body ache | Body ache (Brand Amrutanjan) | Amrutanjan) Congestion (Brand Relief) Q1 FY 26-27: Performance of SKUs Small SKU (1ml) A 20% Head Roll On A 1% 8ml V -23% Q1 FY 26-27: Performance of
Slide 8: Segment Performance: Women's Hygiene and Rehydration
Segment Performance: Women’s Hygiene and Rehydration @ MEN'S HYGIENE RANGE @ 22 wol ane RANGI 2/2) e)™ pe @ | Women’s Hygiene (Brand Comfy) Rehydration (Electro+ & Enerlyte) Gross Sales Growth Drivers (Q1 FY 26-27): Gross Sales Growth Drivers (Q1 FY 26-27): Comfy XL Variant A 43% Electro+ (Tetra) A
Slide 9: New Launches Performance
New Launches Performance New Launches Contribution to Overall AHCL * Inline with the strategic objectives, AHCL entered into new categories, that complements the existing portfolio. Across categories, the following brands were launched in Q4 FY 26 — Women’s Razors, Men’s Razors, Antiseptic Plaster,
Slide 10: Sanitary Napkins Manufacturing Facility
Sanitary Napkins Manufacturing Facility Sanitary Napkins Factory & * AHCL has commissioned its new Greenfield Sanitary Napkin Manufacturing Facility in Telangana * Commissioned recently, the 3150 crore investment marks a major milestone in the company's manufacturing journey and strengthens its comm
Slide 11: Operations Update — Sales and Distribution
Operations Update — Sales and Distribution In line with AHCL’s strategic priorities, several execution enhancement initiatives were implemented to improve operational effectiveness. These Interventions resulted in positive momentum across key sales metrics during Q1 FY 26-27. 7/INN Sales Infrastruct
Slide 12: Operations Update — HR
Operations Update — HR Labour Codes Salary Restructuring * Completed the salary restructuring in line with new wage code Investor Presentation | Quarter Ended 30th June 2026 Sales /Product training for all our field employees (CSEs, ISRs and ABMs). Also new self paced online trainings initiated for
Slide 13: Financials
Financials Investor Presentation | Quarter Ended 30th June 2026
Slide 14: Note on Exceptional Item
Note on Exceptional Item Exceptional item: > During the financial year 2005-06, the Government of Tamil Nadu retrospectively revised the lease rent for a leasehold land, effective from November 2001, by determining fair rent under Section 34A of the Tamil Nadu Hindu Religious and Charitable Endowmen
Slide 15: Financials — Q1 FY27
Financials — Q1 FY27 (Rs. in Crores) Net Sales 102.97 Ql FY27 94.05 Ql FY26 Profit before exceptional item & Tax Growth: 9.48% Ql FY27 Profit Before Tax 11.29 L Ql FY26 11.29 j L Q1 FY27 Q1 FY26 Profit After Tax 8.31 a Q1 FY27 Q1 FY26 Investor Presentation | Quarter Ended 30th June 2026
Slide 16: Segment results — Q1 FY27
Segment results — Q1 FY27 (Rs. in Crores Net Sales - Women’s Hygiene & Personal Care 36.36 Net Sales - OTC Products 28.61 57.26 56.97 Ql FY27 Ql FY26 Growth: 27.09% Ql FY27 Ql FY26 Net Sales - Comfy 33.80 28.61 Q1 FY27 Ql FY26 Ne wy, Growth: 18.14% Notes: * Majority of Raw material & Packing materia
Slide 17: Segment results — Q1 FY27
Segment results — Q1 FY27 (Rs. in Crores) (— Net Sales - Beverages am (— > 8.64 7.76 ¢ Raw material prices are marginally lower than Q1 FY26 and Packing Qi FY27 Qi FY26 . . . material prices are higher than Q1 P76. Net Sales - Hydration drinks * Advertisement spend for Q1 FY27 is at Rs. 0.33 Cr agai
Slide 18: Expenses — Q1 FY27
Expenses — Q1 FY27 (Rs. in Crores) Employee Benefit Expenses 17.62 16.01 Qi FY27 Qi FY26 Advertisement & Selling Expenses 7.81 737 Ql FY27 Ql FY26 Increase : 5.97% Investor Presentation | Quarter Ended 30th June 2026 Increase : 11 Other Expenses 17.01 12.83 Ql FY27 QU FY26 Increase : 32.58%
Slide 19: Management Commentary
Management Commentary sentation | Quarter Ended 30th June 2026
Slide 20: Management Commentary
Management Commentary A. As investors know, 65% of company revenue is contributed from the Pain Management category. When this slows down it has an impact on overall performance Performance of pain management category- Per IQVIA data, the volume growth of the category in Q1 was -3.4% over same perio
Slide 21: Management Commentary
Management Commentary Outlook: Last year saw a robust growth in operating income. The year also saw multiple one time charges (lease rent matter, wage code, inventory loss due to FSSSAI issue)to P and L that would not continue into the new year(the lease rent matter is closed & the additional provis
Slide 22: Investor Presentation | Quarter Ended 30th June 2026
Investor Presentation | Quarter Ended 30th June 2026
Amrutanjan Health Care — Q1 FY27 Earnings Presentation on 6ix